Targeted Therapy to Inhibit Connective Tissue Growth in Pancreatic Cancer
Researchers are testing a new antibody, a type of targeted therapy, in combination with standard treatment for pancreatic cancer in a phase III trial.
In this observational study, researchers are looking at whether irreversible electroporation (also known as IRE) added to standard treatment is…